Eli Lilly / Amgen / Medical Research Council’s Laboratory / Genentech / Pfizer / Elite Pharmaceuticals Inc. / /
Continent
Europe / /
Country
United States / United Kingdom / China / /
Currency
USD / /
Event
FDA Phase / /
Facility
Massachusetts Institute of Technology / Medical Research Council’s Laboratory of Molecular Biology / /
IndustryTerm
therapies for rheumatoid arthritis / an autoimmune disorder / treatment of non-Hodgkin’s lymphoma / hybridoma technology / protein product / biotechnology / pharmaceutical industry / nascent pharmaceutical industry / pharmaceutical forecasters / chemical compounds / lymphoma treatment / pharmaceutical / pharmaceutical manufacturers / manufacturing process / target site / genomic technology / shiny new technology / manufacturing / pharmaceutical products / therapeutic products / chemical structure / chemicals / /
MedicalCondition
systemic lupus erythematosus / lymphoma / counter ulcerative colitis / rheumatoid arthritis / diphtheria / tetanus / B cell lymphoma treatment / melanoma / serum sickness / B cell cancer / multiple sclerosis / disorder / autoimmune disorder / breast cancer / influenza / severe allergic reactions / tumor / several other autoimmune disorders / disease / metastatic colorectal cancer / typhoid / enough cancer / autoimmune disease / diseases / systemic inflammation / anthrax / inflammation / HER2-positive breast cancer / HER2-positive metastatic breast cancer / Raxibacumab Human Genome Sciences Inhalational anthrax / /
MedicalTreatment
antibiotics / chemotherapy / /
Organization
Food and Drug Administration / Harvard / Massachusetts Institute of Technology / US Federal Reserve / Center for Biomedical Innovation / /
Person
J. Christopher Love / Emil von Behring / WENDY SCHELAH FOR HALLEY / Eugen Dhimolea / Shibasaburo Kitasato / Georges Köhler / Anthony Coyle / César Milstein / Niels Jerne / Aaron L. Nelson / David Liu / Janice M. Reichert / LAUREN WARE / /
Position
Prussian military physician / guard / chemical engineer / industry analyst / physician and bacteriologist / chemical biologist / vice president and chief scientific officer / complications Designer / /
38 SCIENTISTS IN MOTION: For researchers and pharmaceutical manufacturers, making small-molecule drugs like aspirin is like building bicycles // Making large-molecule drugs, like jet planes // But with complexity comes